Fibrinogen
Sponsors
West China Hospital, Sichuan University, Astrazeneca AB, Astrazeneca AB, LFB-Biotechnologies, Christian Fenger-Eriksen, Mayo Clinic
Conditions
BleedingBleeding in patients undergoing complex cardiac surgery involving Cardiopulmonary bypassBlood Coagulation DisorderBruisingCardiac Complication During ProcedureComplicationsCoronary Artery DiseaseHaemorrhage
Phase 1
Phase 2
Phase 3
The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery
CompletedNCT01471730
Start: 2011-11-30End: 2014-12-31Updated: 2015-03-31
The Efficacy of the Administration of Fibrinogen in Liver Transplantation
NCT01539057
Start: 2012-07-31End: 2015-01-31Target: 132Updated: 2014-12-04
Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery
CompletedNCT01623531
Start: 2014-02-28End: 2019-06-30Updated: 2020-05-22
A Randomized Study of Andexanet Alfa Compared to Usual Care in Patients Receiving a Factor Xa Inhibitor who Require Urgent Surgery or Procedure (ANNEXA-RS)
CompletedCTIS2022-501353-37-00
End: 2024-06-13Target: 467Updated: 2024-02-19
A multicenter, randomized, double-blind, placebo-controlled, parallel, phase 3 study to assess the efficacy and safety of fibrinogen concentrate (FGTW) in the management of bleeding in patients undergoing complex cardiac surgery (involving CPB)
RecruitingCTIS2024-512388-29-00
Start: 2022-11-29Target: 104Updated: 2025-10-14
Phase 4
Unknown Phase
Study Evaluating Benefit of Using Fibrin Glue in Septorhinoplasty
TerminatedNCT00713596
Start: 2008-07-31End: 2010-01-31Updated: 2016-04-18
Prospective comparison of plasma- or serum-based assays of D-dimer and fibrin degradation product for diagnosing periprosthetic joint infection
Active, not recruitingChiCTR2000038547
Start: 2020-10-20Updated: 2021-03-15